Key Dates

Related Announcements

PAR-21-293 - Clinical and Translational Science Award (UM1 Clinical Trial Optional)

PAR-21-336 - K12 Physician Scientist Award Program (PSA)

Issued by

National Center for Advancing Translational Sciences (NCATS)

Purpose

The purpose of this Notice is to alert potential applicants to expansion of eligibility for PAR-21-336, K12 Physician Scientist Award Program required companion application associated with PAR-21-293, Clinical and Translational Science Award (UM1 Clinical Trial Optional):

The K12 Physician Scientist Award Program required UM1 companion application must be submitted in accordance with the UM1 and K12 FOAs application submission dates under the following scenario:

• Initial Concurrent submission of both a UM1 application to PAR-21-293: Clinical and Translational Science Award and a K12 application to PAR-21-336

The K12 Physician Scientist Award Program required companion application may be resubmitted in accordance with the applicable FOA application submission dates under the following scenarios:

• concurrently with the resubmitted UM1
• while the UM1 application is under review consideration
• after the UM1 application is funded
• while the UM1 is under consideration for funding

While the K12 Physician Scientist Award Program required companion application must be submitted concurrently with the initial UM1 application or resubmitted at any time the submitted UM1 new or resubmission application or award remains active, the K12 Physician Scientist Award Program required companion application will only be awarded if the UM1 is awarded.

As a reminder, NIH will send centralized automated correspondence to applicant organizations notifying them of NIH’s intent not to fund the indicated applications. A consolidated email, listing the applications which NIH does not intend to fund, will be sent by the NIH eRA system to the authorized organization representative (AOR) and signing official (SO) listed in the grant application, and the Notice of Award email address listed in the applicant’s Institutional Profile. The email will be sent approximately 14 months after the application’s council date.

In addition to receiving official email correspondence for NIH, applicants can determine whether the Unfunded Application Notification has been sent for a specific grant application in the eRA Commons. Please also note that the funding decisions indicated in the correspondence are specific to the applications included in the email and have no impact on subsequent submissions, including resubmissions. NIH’s application submission/resubmission policy is outlined in NOT-OD-18-197.

Thus, UM1s that are not selected for funding after a term of 14 months after Council review will generally be considered ineligible for funding and the K12 Physician Scientist Award Program required companion application to the UM1 will no longer be eligible to be submitted and will not be accepted. Note that the 14-month window for funding eligibility also applies to resubmitted applications; that is, the date of Council, constitutes the starting point for the 14-month eligibility window.

Example:

• • UM1 and K12 Physician Scientist Award Program (required component application) submitted May 13, 2022 (January 2023 Council).
  • UM1 is not selected for funding. The K12 Physician Scientist Award Program is meritorious and considered eligible for funding but is not awarded. UM1 is resubmitted September 16, 2022, and the K12 Physician Scientist Award Program applicant chooses not to resubmit the application. The K12 Physician Scientist Award Program application will be under consideration until March 2024 (for up to 14 months after January 2023 Council).

Eligibility Window:

Inquiries

Please direct all inquiries to:

Mercedes Rubio, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-480-8957
Email: [email protected]